Volunteer Assignments and Opportunities

Revision as of 09:41, 28 October 2022 by Bailey.Glen (talk | contribs)

Welcome!

  • For assignments, please see the "Author" column below. If no name is present, volunteer to create content!
  • We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books. If there is an entity not yet listed below that you would like to author in any WHO book, we would be happy to create a page for you now.
  • To volunteer, please Contact us with your page of interest.
  • NOTE: A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated by mid-2023; we're working on a plan to align the related CCGA content to the new structure.

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content

Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myeloproliferative Neoplasms (MPN) Overview Mark Evans (trainee), Fabiola Quintero-Rivera complete Fabiola Quintero-Rivera (FQR) Date page was created
    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive Disease Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera complete FQR Date page was created
    Chronic Neutrophilic Leukemia (CNL) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera complete FQR Date page was created
    Polycythaemia Vera (PV) Disease Gokce A. Toruner complete FQR
    Primary Myelofibrosis (PMF) Disease T. Niroshi Senaratne complete FQR 8/4/2020 before submission
    Essential Thrombocythaemia (ET) Disease Rebecca Smith complete FQR 8/1/21 FQR deleted "This page is under construction
    Chronic Eosinophilic Leukemia, Not Otherwise Specified Disease Chelsea D. Kramish (trainee), Daynna J.Wolff complete/pending faculty review FQR
    Myeloproliferative Neoplasm (MPN), Unclassifiable Disease Thomas Lee complete FQR
Mastocytosis Overview Shashi Shetty, Ph.D. complete FQR
    Cutaneous Mastocytosis Disease Thuy Phung + Shuo-Shawn Liu (trainee) complete FQR 8/1/21 FQR deleted "This page is under construction
    Systemic Mastocytosis Disease Shashi Shetty complete FQR
    Mast Cell Sarcoma Disease Thuy Phung +Jordan Lowery (trainee) complete FQR
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 Overview Daynna J.Wolff complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Disease Jay Alden (trainee) +Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Disease Christopher Sullivan (trainee) + Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Disease Yanna Ding Complete FQR
    Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Disease Jessica Snider (trainee) + Daynna J.Wolff Complete FQR
Myeloid/Lymphoid Neoplasms with ETV6-JAK2 Disease Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myeloid/Lymphoid Neoplasms with BCR-JAK2 Disease Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Overview Linsheng Zhang Complete FQR
    Chronic Myelomonocytic Leukemia (CMML) Disease Linsheng Zhang Complete FQR
    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Disease Linsheng Zhang Complete FQR
    Juvenile Myelomonocytic Leukemia (JMML) Disease Sarah Rapisardo 9/1/20 PENDING importing content and reference formatting FQR FQR has emailed SR several times, last 4/20/22
    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera complete FQR Date page was created
    Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Disease Ruth MacKinnon complete FQR
Myelodysplastic Syndromes (MDS) Overview Jack Reid (trainee)+Fabiola Quintero-Rivera 4/21/22 pending FQR
    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia Disease Xiaoli Du(trainee) +Teresa Smolarek 9/1/20 PENDING FQR
    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia Disease Xiaoli Du(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS) with Excess Blasts Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 Complete FQR
    Myelodysplastic Syndrome (MDS) with Isolated del(5q) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS), Unclassifiable Disease Xiaolin Hu(trainee)+Teresa Smolarek complete FQR
    Refractory Cytopenia of Childhood Disease Xiaoli Du(trainee)+Teresa Smolarek 9/1/20 Complete FQR
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms Overview Daynna Wolff+Daniel Butler (Path Resident) Complete Jennelle Hodge (JH)/ Malini Sathanoori (MS) 04/26/2021 -MS (re-review)
Myeloid Neoplasms with Germline Predisposition Overview Ying Zou Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukaemia with Germline CEBPA Mutation Disease Daynna Wolff+Matthew Kilpatrick (Path Resident) PENDING Complete - awaiting clarification JH / MS 04/26/2021 -MS (re-review) Review completed, awaiting some clarification from JH - 07/04/2022
    Myeloid Neoplasms with Germline DDX41 Mutation Disease Fei Yang Complete JH / MS 03/01/2021-MS
    Myeloid Neoplasms with Germline RUNX1 Mutation Disease Malini Sathanoori Complete 02/03/2021 JH / MS
    Myeloid Neoplasms with Germline ANKRD26 Mutation Disease Fei Yang Complete JH / MS 03/02/2021-MS
    Myeloid Neoplasms with Germline ETV6 Mutation Disease Ying Zou Complete JH / MS 03/02/2021-MS (re-review)
    Myeloid Neoplasms with Germline GATA2 Mutation Disease Daynna Wolff+ Alexandria Avery (Path Resident) Complete JH / MS 04/26/2021 -MS (re-review)
Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Overview Daynna Wolff+ Dan Wang (trainee) Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Disease Christine Bryke Complete JH / MS 04/26/2021-MS (re-review)
    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Disease Christine Bryke Complete JH / MS 03/01/2021-MS (re-review)
    Acute Promyelocytic Leukemia (APL) with PML-RARA Disease Shashi Shetty Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Disease Shashi Shetty Complete JH / MS 03/01/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Disease Jennelle Hodge Complete JH / MS 02/24/2021-MS (re-review)
    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Disease Gordana Raca Complete JH / MS Need permission for figure? Update WHO?
    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with BCR-ABL1 Disease Kay Weng Choy + Greg

Corboy (Monash Health)

Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated NPM1 Disease Xinjie Xu Complete JH / MS Add WHO reference
    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Disease Paul deFazio, MSc + Greg Corboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated RUNX1 Disease Daynna Wolff+Iris Martin (Path Resident) Complete JH / MS
Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Disease Fei Yang Complete JH / MS
Therapy-Related Myeloid Neoplasms Disease Shashi Shetty + Shawn A. Silver (resident) Complete JH / MS Check reference format
Acute Myeloid Leukemia (AML), Not Otherwise Specified Overview Anwar Iqbal Complete JH / MS
    Acute Myeloid Leukemia (AML) with Minimal Differentiation Disease Fabiola Quintero-Rivera and Celeste Eno (fellow) Complete JH / MS
   Acute Myeloid Leukemia (AML) without Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myelomonocytic Leukemia Disease Fei Yang Complete JH / MS
    Acute Monoblastic and Monocytic Leukemia Disease Fei Yang Complete JH / MS
    Pure Erythroid Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Megakaryoblastic Leukemia (AMKL) Disease Fei Yang Complete JH / MS
    Acute Basophilic Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Panmyelosis with Myelofibrosis Disease Ying Zou and Jialing Huang (MGP fellow) Complete JH / MS
Myeloid Sarcoma Disease Fabiola Quintero-Rivera Complete JH / MS
Myeloid Proliferations Associated with Down Syndrome Overview Patty Greipp Complete JH / MS Need permission for figure?
    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
    Myeloid Leukemia Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
Blastic Plasmacytoid Dendritic Cell Neoplasm Disease Daynna Wolff+Hao Liu (Path Resident) Complete JH / MS
Acute Leukemias of Ambiguous Lineage Overview Hui Chen/ Jennelle Hodge Complete JH / MS
    Acute Undifferentiated Leukemia Disease Shashi Shetty + Amelia Nakanishi (resident) Complete JH / MS Check reference format
    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified Disease Shashi Shetty + Priyatharsini Nirmalanantham (resident) Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified Disease Fabiola Quintero-Rivera Complete JH / MS
    Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types Disease Daynna Wolff+ Elicia Goodale (resident) PENDING JH / MS
    Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS) Disease Daynna Wolff+Madison Hannay or Elicia Goodale (residents) PENDING JH / MS
Acute Myeloid Leukemia (AML) with Mutated FLT3 Disease Kay Weng Choy + Greg Corboy (Monash Health) Complete JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with NUP214-ABL1 Disease Daynna Wolff+Jessica Snider (Path Resident) PENDING JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 Disease Daynna Wolff+ Paige Woodham (Path Resident) PENDING JH / MS NON-WHO ENTITY
Precursor Lymphoid Neoplasms Overview Yassmine Akkari (YA)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Overview YA
    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     Disease Afia Hasnain (trainee) + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged Disease Yassmine Akkari+Nicolas Millan (trainee) PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 Disease Marilena Melas + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy Disease Afia Hasnain + Yassmine Akkari PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Disease Ashwini Yenamandra +

Lisa Smith + Yassmine Akkari

Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 Disease Binu Porath + Linda Cooley PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 Disease Binu Porath + Linda Cooley PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Disease Mark G. Evans + Fabiola Quintero-Rivera Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with iAMP21 Disease Holli Drendel Complete YA
    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified Disease Holli Drendel PENDING YA
B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 Disease Diana Rush PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 Disease Celeste Eno PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements Disease Marilena Melas PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions Disease Chenkai Ma PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19) Disease Celeste Eno PENDING YA NON-WHO ENTITY
B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) Disease Alaa Koleilat PENDING YA NON-WHO ENTITY
T-Lymphoblastic Leukemia/Lymphoma Overview Fei Yang PENDING YA
Early T-Cell Precursor Lymphoblastic Leukemia Disease Fei Yang PENDING YA 2021 template added
NK-Lymphoblastic Leukemia/Lymphoma Disease Fei Yang PENDING YA 2021 template added
Mature B-Cell Neoplasms Overview Snehal Patel (SP)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Disease SP
       Monoclonal B-cell Lymphocytosis Disease SP 2021 template added
B-cell Prolymphocytic Leukemia Disease Zejuan Li 4/28/22 PENDING SP 2021 template added
Splenic Marginal Zone Lymphoma Disease Snehal Patel Complete SP
Hairy Cell Leukemia Disease Snehal Patel Complete SP
Splenic B-cell Lymphoma/Leukemia, Unclassifiable Overview Snehal Patel Complete SP
    Splenic Diffuse Red Pulp Small B-cell Lymphoma Disease Snehal Patel Complete SP
    Hairy Cell Leukemia Variant Disease Snehal Patel Complete SP
Lymphoplasmacytic Lymphoma Disease Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera PENDING review by FQR SP 2021 template added
   Waldenstrom Macroglobulinemia Disease Kapitolina Semenova (trainee)+Fabiola Quintero-Rivera PENDING review by FQR SP 2021 template added
IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
Heavy Chain Diseases Overview SP
    Mu Heavy Chain Disease Disease SP
   Gamma Heavy Chain Disease Disease Manisha Sutariya Complete 5/26/2021 SP
    Alpha Heavy Chain Disease Disease SP
Plasma Cell Neoplasms Overview Zhenya Tang PENDING SP
   Non-IgM Monoclonal Gammopathy of Undetermined Significance Disease Zhenya Tang PENDING SP
    Plasma Cell Myeloma Disease Zhenya Tang/Huang Mo (trainee) PENDING SP
    Plasma Cell Myeloma Variants Disease Fariborz Rashid-Kolvear PENDING SP
    Plasmacytoma Disease Zhenya Tang PENDING SP
    Monoclonal Immunoglobulin Deposition Diseases Overview Chen Yang, MD, PhD Complete 09/10/2022 SP
           Primary Amyloidosis Disease Heather E. Williams, PhD ?PENDING SP
           Light Chain and Heavy Chain Deposition Disease Disease Chen Yang, MD, PhD Complete 10/15/2022 SP
Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome Overview Sohini Anand 8/31/2021 9/15/2021 PENDING SP
         POEMS Syndrome Disease Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD ?PENDING SP
         TEMPI Syndrome Disease Sohini Anand, MBBS ?PENDING SP
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Disease Whayoung Lee (trainee)/Fabiola Quintero-Rivera 3/9/21 PENDING SP 2021 template added
Nodal Marginal Zone Lymphoma Disease Shivani Golem Complete 5/28/2021 SP
    Paediatric Nodal Marginal Zone Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) Complete 11/11/2020 SP
Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    Testicular Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    In Situ Follicular Neoplasia Disease Ruthann Pfau PENDING SP
    Duodenal-Type Follicular Lymphoma Disease Ruthann Pfau PENDING SP
Paediatric-Type Follicular Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) Complete 8/16/2020 SP
Large B-cell Lymphoma with IRF4 Rearrangement Disease Afia Hasnaid 9/30/20 Complete 5/26/2021 SP
Primary Cutaneous Follicle Centre Lymphoma Disease Shivani Golem Complete 09/10/2022 SP
Mantle Cell Lymphoma Disease Mahsa Khanlari 8/15/20 PENDING SP
    Leukemic Non-Nodal Mantle Cell Lymphoma Disease Mahsa Khanlari, MD ?PENDING SP
    In Situ Mantle Cell Neoplasia Disease Rina Kansal, MD 6/12/22 Complete 7/26/2022 SP 2021 template added
Diffuse Large B-cell Lymphoma, Not Otherwise Specified Disease Ashwini Yenamandra PENDING Greg Corboy (GC) Requested to update 14022022
T-cell/Histiocyte-Rich Large B-cell Lymphoma Disease GC
Primary Diffuse Large B-cell Lymphoma of the CNS Disease Laveniya Satgunaseelan 26/10/2021 26/1/2022 Complete 03/28/22 GC 03/28/22 2021 template added
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type Disease GC
EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
EBV-Positive Mucocutaneous Ulcer Disease GC
Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation Disease GC
    Fibrin-Associated Diffuse Large B-cell Lymphoma Disease GC
Lymphomatoid Granulomatosis Disease GC
Primary Mediastinal (Thymic) Large B-cell Lymphoma Disease GC
Intravascular Large B-cell Lymphoma Disease Kate Berry, Greg Corboy 25/01/2022 25/4/2022 Complete 9/1/22 GC 9/1/22 Emailed 28/3/2022 for progress update
ALK-Positive Large B-cell Lymphoma Disease Nakasaki Manando PENDING GC Nakasaki Manando removed March 2022 due to no progress/contact 1y. Added Nakasaki Manando back n 8/29/22 based on newer email communication (Jennelle's note). 2021 template added.
Plasmablastic Lymphoma Disease Mark Evans (trainee), Fabiola Quintero-Rivera Complete GC 28/03/2022
Primary Effusion Lymphoma Disease GC
HHV8-Associated Lymphoproliferative Disorders Overview GC
   Multicentric Castleman Disease Disease Sudha Arumugam 10/26/2021 1/26/2022 Complete 24/01/2022 GC 24/01/2022 2021 template added
   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease Xiao Zhou, MD, PhD, Siparadigm 10/26/2021 1/26/2022 PENDING GC Emailed 28/3/2022 for progress update
   HHV8-Positive Germinotropic Lymphoproliferative Disorder Disease Xiao Zhou, MD, PhD, Siparadigm 10/26/2021 1/26/2022 PENDING GC Emailed 28/3/2022 for progress update
Burkitt Lymphoma Disease Becky Leung (trainee), Greg Corboy 3/11/21 06/28/2021 Complete 28/06/2021 GC 28/06/2021
Burkitt-Like Lymphoma with 11q Aberration Disease Lauren Shealy (trainee), Daynna Wolff 10/13/21 01/13/2022 Complete 27/01/2022 GC 27/01/2021 2021 template added
High-Grade B-cell Lymphoma Overview GC
    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Disease Kate Berry, Greg Corboy 30/05/21 30/08/21 Complete 24/02/2022 GC 24/02/2022
    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) Disease Aiko Otsubo, Holli Drendel 7/30/21 10/30/21 Complete 15/11/2021 GC 16/11/2021
B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma Disease GC
Mature T- and NK-cell Neoplasms Overview Snehal Patel (SP)
T-cell Prolymphocytic Leukemia Disease Michelle Don PENDING SP
T-cell Large Granular Lymphocytic Leukemia Disease Michelle Don PENDING SP
Chronic Lymphoproliferative Disorder of NK Cells Disease Michelle Don PENDING SP
Aggressive NK-cell Leukemia Disease Shanelle De Lancy, MD, Shashirekha Shetty, PhD ?PENDING SP
EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood Overview SP
  Systemic EBV-Positive T-cell Lymphoma of Childhood Disease Lisa Lansdon (trainee) Complete 11/21/2021 SP
   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form Disease SP
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder Disease SP
    Severe Mosquito Bite Allergy Disease SP
Adult T-cell Leukemia/Lymphoma Disease Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG ?PENDING SP
Extranodal NK/T-cell Lymphoma, Nasal Type Disease SP
Intestinal T-cell Lymphoma Overview Sumire Kitahara, Derick Okwan (trainee) Complete 9/26/2022 SP
    Enteropathy-Associated T-cell Lymphoma Disease Sumire Kitahara, Derick Okwan (trainee) Complete 1/21/2021 SP
     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Disease Sumire Kitahara PENDING SP
     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) Disease Sumire Kitahara, Derick Okwan (trainee) Complete 9/26/2022 SP
    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
Hepatosplenic T-cell Lymphoma Disease Michelle Don Complete 1/21/2021 SP
Subcutaneous Panniculitis-Like T-cell Lymphoma Disease SP
Mycosis Fungoides Disease Daynna Wolff, Jane Scribner (trainee) PENDING SP
Sézary Syndrome Disease Daynna Wolff, Madison Hannay (trainee), Tingting Barrett (trainee) PENDING SP
Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders Overview Peining Li, PhD PENDING SP
    Lymphomatoid Papulosis Disease Peining Li, PhD PENDING SP
    Primary Cutaneous Anaplastic Large Cell Lymphoma Disease Theresa Spivey, MD, Shashirekha Shetty, PhD PENDING SP
Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes Overview Peining Li, PhD PENDING SP
     Primary Cutaneous Gamma Delta T-cell Lymphoma Disease Peining Li, PhD PENDING SP
     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Disease Peining Li, PhD PENDING SP
     Primary Cutaneous Acral CD8+ T-cell Lymphoma Disease Peining Li, PhD PENDING SP
     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder Disease Peining Li, PhD PENDING SP
Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) Disease SP
Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin Overview SP
     Angioimmunoblastic T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
    Follicular T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype Disease Hans Hamnvåg PENDING SP
Anaplastic Large Cell Lymphoma, ALK-Positive Disease Sumire Kitahara / Miguel Gonzalez (trainee) Completed 09/23/2022 SP
Anaplastic Large Cell Lymphoma, ALK-Negative Disease Sumire Kitahara / Miguel Gonzalez (trainee) Completed 09/23/2022 SP
Breast Implant-Associated Anaplastic Large Cell Lymphoma Disease Sumire Kitahara PENDING SP
Hodgkin Lymphomas Overview Greg Corboy (GC)
Nodular Lymphocyte Predominant Hodgkin Lymphoma Disease Thomas Harrington (resident) + Daynna Wolff 06/22/2022 09/22/2022 PENDING GC 2021 template added, Daynna organising
Classic Hodgkin Lymphoma Overview GC
    Nodular Sclerosis Classic Hodgkin Lymphoma Disease Xiaolin (Lynn) Hu Completed 03/21/22 GC 03/21/22 Edits sent 14022022
    Lymphocyte-Rich Classic Hodgkin Lymphoma Disease Patricia V. Hernandez, M.D. (trainee)+Holli Drendel PENDING GC 2021 template added
    Mixed Cellularity Classic Hodgkin Lymphoma Disease Patricia V. Hernandez, M.D. (trainee)+Holli Drendel PENDING GC 2021 template added
    Lymphocyte-Depleted Classic Hodgkin Lymphoma Disease Patricia V. Hernandez, M.D. (trainee)+Holli Drendel PENDING GC 2021 template added
Immunodeficiency-Associated Lymphoproliferative Disorders Overview GC
Lymphomas Associated with HIV Infection Disease Patricia V. Hernandez, M.D. (trainee)+Holli Drendel 11/2/21 02/02/22 Completed 03/21/22 GC 03/21/22 2021 template added
Post-Transplant Lymphoproliferative Disorders Overview GC
    Non-Destructive Post-Transplant Lymphoproliferative Disorders Disease GC
    Polymorphic Post-Transplant Lymphoproliferative Disorders Disease Ania Shestakova (trainee) + Fabiola Quintero-Rivera completed april 2022 GC 26/4/2022
    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) Overview GC
          Monomorphic B-cell PTLD Disease GC
          Monomorphic T/NK-cell PTLD Disease GC
    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Disease GC
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Disease GC
Histiocytic and Dendritic Cell Neoplasms Overview GC
Histiocytic Sarcoma Disease Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic Complete 10/01/2021 GC 10/01/2021 Xinjie Xu
Tumors Derived From Langerhans Cells Overview GC
   Langerhans Cell Histiocytosis Disease Malaika Perchard, Greg Corboy 02/01/2022 05/01/2022 Complete 04/28/2022 GC 5/19/2022
   Langerhans Cell Sarcoma Disease Malaika Perchard, Greg Corboy 02/01/2022 05/01/2022 Complete 04/28/2022 GC 5/19/2022
Indeterminate Dendritic Cell Tumour Disease GC
Interdigitating Dendritic Cell Sarcoma Disease GC
Follicular Dendritic Cell Sarcoma Disease GC
    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma Disease GC
Fibroblastic Reticular Cell Tumor Disease GC
Disseminated Juvenile Xanthogranuloma Disease GC
Erdheim-Chester Disease Disease Prashant Deshpande 02/02/2022 05/02/2022 PENDING GC emailed 28/3/2022 to get update


WHO Classification of Tumours of the Central Nervous System Content

Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Paediatric-Type Diffuse High-Grade Gliomas Overview 2021 template added
Diffuse Midline Glioma, H3 K27-Altered Disease Laveniya Satgunaseelan (Linda Cooley - previous version) PENDING Laveniya Satgunaseelan (LS) 2021 template added
Diffuse Hemispheric Glioma, H3 G34-Mutant Disease Xiaolin (Lynn) Hu 2/21/2022 PENDING LS 2021 template added
Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype Disease 2021 template added
Infant-Type Hemispheric Glioma Disease 2021 template added
Astrocytoma, IDH-Mutant Disease Riley Lochner (trainee), Shashi Shetty (mentor) 3/3/2022 PENDING LS 2021 template added
Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 3/3/2022 PENDING LS 2021 template added
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 PENDING LS 2021 template added
Pilocytic Astrocytoma Disease Jeremy Pulvers 9/13/2022 PENDING LS 2021 template added


WHO Classification of Soft Tissue and Bone Tumours Content

Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
NTRK-Rearranged Spindle Cell Neoplasm Disease James Solomon, MD, PhD 2/20/2022 PENDING Alanna Church


WHO Classification of Tumours of Breast Tumours Content

Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Adenoid Cystic Carcinoma Disease Katherine Geiersbach 10/12/02022 PENDING Hui Chen 2021 template added
Secretory Carcinoma Disease Hui Chen 10/12/2022 PENDING Katherine Geiersbach 2021 template added


Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)

Gene Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BCR Brian Davis Complete 8/10/18
ABL1 Brian Davis Complete 4/16/19
RUNX1 Brian Davis Complete 6/9/19
RUNX1T1 Brian Davis Complete 5/23/19
MYH11 Brian Davis Complete 8/6/18
FLT3 Kay Weng Choy Complete
NPM1 Kay Weng Choy Complete
TP53 Kay Weng Choy Complete
DNMT3A Kay Weng Choy Complete
CEBPA Gordana Complete
IDH1 Paul De Fazio Complete
IDH2 Paul De Fazio Complete
PML Brian Davis Complete 12/5/18
RARA Brian Davis Complete 8/3/18
ETV6 Brian Davis Complete 6/9/19
KIT Brian Davis Complete 10/1/18
CBFB Brian Davis Complete 8/2/18
GATA2 Kay Weng Choy Complete
PTEN Beth Pitel Pending
MLTT3
MECOM Brian Davis Pending
FGFR1(FLT2) Brian Davis Pending
KMT2A
DEK Wahab A. Khan Pending
NUP214 Wahab A. Khan Pending
RBM15
MKL1
DDX41 Ying Zou 8/7/20 Pending
ANKRD26
CUX1
TET2
EZH2
FOXP1
MYC
JAK2
WT1 DONE DONE
CBL
NF1
SUZ12
ERG
EST2
RPS14
RB1
MPL
CHGA
CDH1
SRSF2
DNMT1
PRDX2
ASXL1 DONE DONE
MN1
SF3A1
EP300
JARID2
BRCA1
BRCA2

WHO Central Nervous System Tumours (5th ed.) Content

Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease
Glioblastoma, IDH-wildtype Disease
Diffuse astrocytoma, MYB- or MYBL1-altered Disease
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease
Diffuse midline glioma, H3 K27-altered Disease
Diffuse hemispheric glioma, H3 G34-mutant Disease
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
Medulloblastoma, WNT-activated Disease
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
Meningioma Disease
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
Germ cell tumours of the CNS Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
Neurofibromatosis type 1 Disease
Neurofibromatosis type 2 Disease
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease
Cowden syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease
Familial adenomatous polyposis 1 Disease
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease
ELP1-medulloblastoma syndrome Disease

WHO Breast tumours (5th ed.) Content

Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Columnar cell lesions, including flat epithelial atypia Disease
Atypical ductal hyperplasia Disease
Sclerosing adenosis Disease
Apocrine adenosis and adenoma Disease
Microglandular adenosis Disease
Radial scar / complex sclerosing lesion Disease
Tubular adenoma Disease
Lactating adenoma Disease
Ductal adenoma Disease
Pleomorphic adenoma Disease
Adenomyoepithelioma Disease
Malignant adenomyoepithelioma Disease
Intraductal papilloma Disease
Papillary ductal carcinoma in situ Disease
Encapsulated papillary carcinoma Disease
Solid papillary carcinoma (in situ and invasive) Disease
Invasive papillary carcinoma Disease
Atypical lobular hyperplasia Disease
Lobular carcinoma in situ Disease
Ductal carcinoma in situ Disease
Invasive breast carcinoma: General overview Disease
Invasive breast carcinoma of no special type Disease
Microinvasive carcinoma Disease
Invasive lobular carcinoma Disease
Tubular carcinoma Disease
Cribriform carcinoma Disease
Mucinous carcinoma Disease
Mucinous cystadenocarcinoma Disease
Invasive micropapillary carcinoma Disease
Carcinoma with apocrine differentiation Disease
Metaplastic carcinoma Disease
Acinic cell carcinoma Disease
Adenoid cystic carcinoma Disease
Secretory carcinoma Disease
Mucoepidermoid carcinoma Disease
Polymorphous adenocarcinoma Disease
Tall cell carcinoma with reversed polarity Disease
Neuroendocrine tumour Disease
Neuroendocrine carcinoma Disease
Hamartoma Disease
Fibroadenoma Disease
Phyllodes tumour Disease
Syringomatous tumour Disease
Nipple adenoma Disease
Paget disease of the breast Disease
Haemangioma Disease
Angiomatosis Disease
Atypical vascular lesions Disease
Postradiation angiosarcoma of the breast Disease
Primary angiosarcoma of the breast Disease
Nodular fasciitis Disease
Myofibroblastoma Disease
Desmoid fibromatosis Disease
Inflammatory myofibroblastic tumour Disease
Schwannoma Disease
Neurofibroma Disease
Granular cell tumour Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Lipoma Disease
Angiolipoma Disease
Liposarcoma Disease
Pseudoangiomatous stromal hyperplasia Disease
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) Disease
Follicular lymphoma Disease
Diffuse large B-cell lymphoma Disease
Burkitt lymphoma Disease
Breast implant-associated anaplastic large cell lymphoma Disease
Gynaecomastia Disease
Carcinoma in situ Disease
Invasive carcinoma Disease
Metastases to the breast Disease
BRCA1/2-associated hereditary breast and ovarian cancer syndrome Disease
Cowden syndrome Disease
Ataxia-telangiectasia Disease
Li-Fraumeni syndrome, TP53-associated Disease
Li-Fraumeni syndrome, CHEK2-associated Disease
CDH1-associated breast cancer Disease
PALB2-associated cancers Disease
Peutz-Jeghers syndrome Disease
Neurofibromatosis type 1 Disease